Clinical Trials on Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma in Korea, Democratic People's Republic of
Total 164 results
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Yonsei UniversityActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Korea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedHead and Neck NeoplasmKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic Carcinoma | Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityNot yet recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Samyang Biopharmaceuticals CorporationUnknownHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaTerminatedHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Janssen Research & Development, LLCRecruitingRecurrent/Metastatic Head and Neck Squamous Cell CarcinomaKorea, Republic of, Taiwan, Malaysia, United States
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
TakedaRecruitingColorectal Cancer | Non-small Cell Lung Cancer (NSCLC) | Squamous Cell Cancer of Head and Neck (SCCHN)Korea, Republic of, United States, Australia
-
Samsung Medical CenterUnknownCuratively-resected, Node-positive Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityUnknownSquamous Cell Carcinoma of EsophagusKorea, Republic of
-
Samsung Medical CenterOno Pharmaceutical Co. LtdUnknownEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Asan Medical CenterTerminatedEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityCompletedEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
Samsung Medical CenterWithdrawn
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of the Head and NeckFrance, United States, Israel, Korea, Republic of, Australia
-
Samsung Medical CenterUnknownEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityUnknown
-
Samsung Medical CenterMinistry of Health & Welfare, KoreaActive, not recruitingEsophageal CancerKorea, Republic of
-
Yonsei UniversityUnknownTumor Disease Including Colorectal Cancer | Head & Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityCompletedEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckChina, Korea, Republic of
-
Samsung Medical CenterUnknownFirst Line Chemotherapy | Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel | Advanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
Merus N.V.RecruitingGastric Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, Spain, France, Italy, Netherlands, Belgium, Korea, Republic of, Germany, Singapore
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Korea, Republic of, United Kingdom, Spain, Belgium, Singapore, Canada, Netherlands, Australia
-
Eisai Inc.PharmaBio Development Inc.CompletedPlatinum-Resistant Squamous Cell Carcinoma of the Head and NeckUnited States, Korea, Republic of, Ukraine, United Kingdom
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingHead and Neck CancerCanada, Spain, Korea, Republic of, United States, Austria, Japan, United Kingdom, Taiwan, Italy, Hungary, Australia, Turkey, Poland, Portugal
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Korea, Republic of, Spain, Greece, Germany, Japan
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Carcinoma (HNSCC)United States, Australia, Austria, Brazil, France, Israel, Korea, Republic of, Norway, Spain, United Kingdom